LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Vorinostat | 0.0033333 | 10.06 | 770.25 | 1422 | 1218 | 1.1670 | 1.5258 | MN20160304_L02 | M14 |
| MCF 10A-H2B-mCherry | Vorinostat | 0.31623 | 16.00 | 771.67 | 1850 | 1585 | 1.1668 | 1.3202 | MN20160304_L01 | K08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 20.44 | 771.67 | 2229 | 1910 | 1.1665 | 1.2498 | MN20160304_L01 | J13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 44.89 | 771.67 | 6464 | 5541 | 1.1665 | 1.1113 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 3.21 | 770.25 | 1055 | 904 | 1.1662 | 2.8806 | MN20160304_L02 | K19 |
| MCF 10A-H2B-mCherry | Vorinostat | 0.17783 | 76.75 | 770.25 | 13135 | 11262 | 1.1662 | 1.0811 | MN20160304_L02 | J13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.66 | 770.25 | 1271 | 1090 | 1.1661 | 1.7178 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Taxol | 0.000043333 | 84.92 | 771.67 | 14302 | 12266 | 1.1659 | 1.0784 | MN20160304_L01 | I16 |
| MCF 10A-H2B-mCherry | Vorinostat | 0.0033333 | 25.62 | 770.25 | 2932 | 2514 | 1.1659 | 1.1881 | MN20160304_L02 | M14 |
| MCF 10A-H2B-mCherry | Taxol | 0.0018 | 11.56 | 771.67 | 1493 | 1280 | 1.1658 | 1.4673 | MN20160304_L01 | L06 |
| MCF 10A-H2B-mCherry | Alpelisib | 0.01 | 76.75 | 770.25 | 13126 | 11262 | 1.1654 | 1.0807 | MN20160304_L02 | J15 |
| MCF 10A-H2B-mCherry | Taxol | 0.000043333 | 60.44 | 771.67 | 9941 | 8530 | 1.1653 | 1.0903 | MN20160304_L01 | I16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 25.62 | 770.25 | 2930 | 2514 | 1.1651 | 1.1872 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Taxol | 0.00013333 | 3.21 | 770.25 | 1054 | 904 | 1.1651 | 2.8648 | MN20160304_L02 | N13 |
| MCF 10A-H2B-mCherry | Taxol | 0.000043333 | 38.95 | 770.25 | 5293 | 4543 | 1.1649 | 1.1228 | MN20160304_L02 | L12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 9.16 | 771.67 | 1326 | 1138 | 1.1647 | 1.6244 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Etoposide | 0.31623 | 9.16 | 771.67 | 1326 | 1138 | 1.1647 | 1.6244 | MN20160304_L01 | J21 |
| MCF 10A-H2B-mCherry | Taxol | 0.0056234 | 16.00 | 771.67 | 1845 | 1585 | 1.1637 | 1.3142 | MN20160304_L01 | K11 |
| MCF 10A-H2B-mCherry | Taxol | 0.000043333 | 78.98 | 770.25 | 13400 | 11518 | 1.1634 | 1.0791 | MN20160304_L02 | L12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 16.00 | 771.67 | 1844 | 1585 | 1.1630 | 1.3130 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 33.78 | 771.67 | 4070 | 3499 | 1.1630 | 1.1434 | MN20160304_L01 | J06 |
| MCF 10A-H2B-mCherry | Taxol | 0.000043333 | 47.83 | 770.25 | 7238 | 6223 | 1.1630 | 1.1027 | MN20160304_L02 | L12 |
| MCF 10A-H2B-mCherry | 0 | 78.98 | 770.25 | 13392 | 11518 | 1.1627 | 1.0788 | MN20160304_L02 | I18 | |
| MCF 10A-H2B-mCherry | Taxol | 0.000043333 | 45.61 | 770.25 | 6758 | 5813 | 1.1626 | 1.1060 | MN20160304_L02 | L12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 55.99 | 771.67 | 8940 | 7690 | 1.1625 | 1.0929 | MN20160304_L01 | J19 |